VERTEX PHARMACEUTICALS INC / MA
For the period ended Dec 31, 2025. Filed Feb 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 13, 2026
VRTX$547.89-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3. Legal Proceedings
Other than as described in Note P, “Commitments and Contingencies,” to our consolidated financial statements, we are
not currently subject to any material legal proceedings.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.